Table 1.
Characteristic† | Overall N=2374 |
Non-Hispanic White N=1907 |
Non-Hispanic Black N=394 |
p-value |
---|---|---|---|---|
Age (years) | <.001 | |||
<60 | 699 (29.4%) | 517 (27.1%) | 155 (39.3%) | |
60–64 | 508 (21.4%) | 401 (21.0%) | 89 (22.6%) | |
65–69 | 558 (23.5%) | 472 (24.8%) | 72 (18.3%) | |
70–74 | 347 (14.6%) | 288 (15.1%) | 48 (12.2%) | |
≥75 | 262 (11.0%) | 229 (12.0%) | 30 (7.6%) | |
| ||||
Insurance | <.001 | |||
Private | 1309 (55.1%) | 1070 (56.1%) | 205 (52.0%) | |
Medicaid | 72 (3.0%) | 23 (1.2%) | 42 (10.7%) | |
Medicare | 956 (40.3%) | 787 (41.3%) | 138 (35.0%) | |
| ||||
Income | <.001 | |||
<$25,000 | 306 (12.9%) | 130 (6.8%) | 152 (38.6%) | |
$25,000–49,999 | 389 (16.4%) | 306 (16.1%) | 76 (19.3%) | |
$50,000–74,999 | 365 (15.4%) | 309 (16.2%) | 44 (11.2%) | |
$75,000–99,999 | 313 (13.2%) | 261 (13.7%) | 45 (11.4%) | |
≥$100,000 | 740 (31.2%) | 691 (36.2%) | 37 (9.4%) | |
| ||||
Education | <.001 | |||
Some high school | 176 (7.4%) | 91 (4.8%) | 68 (17.3%) | |
High school grad/GED | 588 (24.8%) | 437 (22.9%) | 134 (34.0%) | |
Some college/2-year degree | 509 (21.4%) | 390 (20.5%) | 101 (25.6%) | |
4-year college grad | 381 (16.1%) | 336 (17.6%) | 37 (9.4%) | |
>4-year college degree | 665 (28.0%) | 609 (31.9%) | 45 (11.4%) | |
| ||||
Marital Status | <.001 | |||
Married | 1895 (79.8%) | 1603 (84.1%) | 232 (58.9%) | |
Not married | 444 (18.7%) | 282 (14.8%) | 149 (37.8%) | |
| ||||
Life Expectancy | <.001 | |||
<25% mortality | 739 (31.1%) | 606 (31.8%) | 110 (27.9%) | |
25–50% mortality | 743 (31.3%) | 639 (33.5%) | 85 (21.6%) | |
50–75% mortality | 532 (22.4%) | 409 (21.5%) | 108 (27.4%) | |
>75% mortality | 216 (9.1%) | 154 (8.1%) | 52 (13.2%) | |
| ||||
Gleason Score | 0.02 | |||
<7 | 940 (39.6%) | 776 (40.7%) | 131 (33.3%) | |
7 | 946 (39.9%) | 741 (38.9%) | 175 (44.4%) | |
>7 | 413 (17.4%) | 331 (17.4%) | 73 (18.5%) | |
| ||||
AJCC clinical tumor stage | 0.10 | |||
Stage 1 | 1695 (71.4%) | 1346 (70.6%) | 294 (74.6%) | |
Stage 2 | 573 (24.1%) | 477 (25.0%) | 79 (20.1%) | |
Stage 3 | 58 (2.4%) | 45 (2.4%) | 12 (3.1%) | |
| ||||
Receipt of Definitive Treatment | 0.09 | |||
Yes | 2028 (85.4%) | 1639 (90.0%) | 330 (83.8%) | |
No | 295 (12.4%) | 224 (11.8%) | 59 (15.0%) | |
| ||||
Radical Prostatectomy | 0.40 | |||
Yes | 1223 (51.5%) | 992 (52.0%) | 192 (49.8%) | |
No | 1053 (44.4%) | 838 (43.9%) | 182 (46.2%) | |
| ||||
Communication | <.001 | |||
Good | 1631 (68.7%) | 1346 (70.6%) | 237 (60.2%) | |
Not Good | 718 (30.2%) | 542 (28.4%) | 152 (38.6%) | |
| ||||
Perceived Quality | <.001 | |||
Good | 1860 (78.4%) | 1538 (80.7%) | 270 (68.5%) | |
Not Good | 438 (18.5%) | 310 (16.3%) | 111 (28.2%) |
Abbreviation: GED, General Educational Development; AJCC, American Joint Committee on Cancer
Race stratified columns exclude 73 men of Hispanic ethnicity or not white or black race.
Certain characteristics do not add up to 100% due to missing data.